rs1037688328
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003630.3(PEX3):c.-231G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PEX3
NM_003630.3 5_prime_UTR
NM_003630.3 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.729
Genes affected
PEX3 (HGNC:8858): (peroxisomal biogenesis factor 3) The product of this gene is involved in peroxisome biosynthesis and integrity. It assembles membrane vesicles before the matrix proteins are translocated. Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause Zellweger syndrome (ZWS). [provided by RefSeq, Oct 2008]
ADAT2 (HGNC:21172): (adenosine deaminase tRNA specific 2) Predicted to enable tRNA-specific adenosine-34 deaminase activity. Predicted to be involved in tRNA wobble adenosine to inosine editing. Predicted to be located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX3 | ENST00000367591.5 | c.-231G>A | 5_prime_UTR_variant | Exon 1 of 12 | 1 | NM_003630.3 | ENSP00000356563.4 | |||
PEX3 | ENST00000367592.5 | c.-231G>A | 5_prime_UTR_variant | Exon 1 of 7 | 5 | ENSP00000356564.1 | ||||
ADAT2 | ENST00000237283.9 | c.-154C>T | upstream_gene_variant | 1 | NM_182503.3 | ENSP00000237283.8 | ||||
ADAT2 | ENST00000367593.1 | n.-139C>T | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 680912Hom.: 0 Cov.: 9 AF XY: 0.00 AC XY: 0AN XY: 355938
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
680912
Hom.:
Cov.:
9
AF XY:
AC XY:
0
AN XY:
355938
African (AFR)
AF:
AC:
0
AN:
17588
American (AMR)
AF:
AC:
0
AN:
28576
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
17048
East Asian (EAS)
AF:
AC:
0
AN:
33658
South Asian (SAS)
AF:
AC:
0
AN:
59254
European-Finnish (FIN)
AF:
AC:
0
AN:
33906
Middle Eastern (MID)
AF:
AC:
0
AN:
2648
European-Non Finnish (NFE)
AF:
AC:
0
AN:
454108
Other (OTH)
AF:
AC:
0
AN:
34126
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.